Clinical trial
Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals…
NCT00455702 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00455702 |
|---|---|
| Title | Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia |
| Official title | Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | d-cycloserine |
| Enrollment | 38 |
| Start date | Jul 1, 2004 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Apr 4, 2007 |
| Last update posted | Aug 7, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: